Member Info for urbansea89

Thanks guys. Been a long day. Need to have few days off all this :)

Impossible to call tomorrow Neavo, I’m just glad this isn’t a Covid stock!
Just!

If they say they're only making decisions based on data and they're not re-opening hospitality until mid summer, the data must be pretty terrible. It should be a lot better by now considering we've been shut down for so long. and vast numbers of vaccinations. There must be more to this than is apparent.

Were Avacta obliged to Twitter today's RNS aswell?
Regardless, I thought it was a skillfully and well crafted statement. Whilst telling us little, it has told us so much more.
Good professional job. In good hands with whoever has authored.

o tej porze w przyszlym roku bedziemy milionerami

All as we were. I’d be staggered if I was able to get in for more tomorrow morning. If that is the case I’ll be all over it and sit tight until the glorious moment. Never thought I’d load up more than I already have but hey, it’d be rude not to.

Hard to say where it would end up Kong but certainly a big piece of it.
The staggering thing about this business is that it has more than tests and AV6000 (which would be more than enough). It’s pipeline will begin to unlock more quickly as each success comes and cash supports it.
Personally my ongoing FOMO will be around for many years to come. I’ll proudly be here for the long haul.

and in terms of views on AV6000 value. IF it works and IF it scores 9/10 put of 10, it could render a large proportion of the 50B chemo market obsolete without the combo. How does that get valued?

The big unknown is the non uk part. Once the quality and reliability of our test and the unlocking model get recognition, there is likely to be a big demand for the product and license from manufacturers all over.
It could be vast and beyond any expectation. Hand in hand, the model is likely to have more longevity. Why would anyone risk descaling easy testing once it’s become commonplace and reliable? It doesn’t make sense.
It’s hard to put any number on it but will become apparent quickly with uptake overseas and new deals being announced. Will then make it possible for growth forecasts to be extrapolated. My feeling is that the scale and longevity will surprise everyone.

Most likely another stampede on Tues morn after announcements on Monday Eve. Then we’ll get the TU and then a series of further RNS’s Re licenses, scores of manufacturing partners who will be queuing up to be approved by Al and team. Then the US deals. That should keep us busy enough until mid year AV6000 initial clinical findings. Blimey, I’ve must likely forgotten a whole bunch of other stuff due to drop.

Sure we could save Japan Olympics. Must come on the radar soon if nothing already being pitched.

The share of the chemo market alone could be worth 5B + in revenue within 3/5 years if it comes off, multiplied by 40. Would put it a long way past that number

a gem amongst so much quality on this board. Take a bow

Just logged on and seen the BB news. Congrats everyone. Never in doubt! Enjoy the weekend, lots of great reads coming up.
Thoroughly deserved.

yes that's the one that worked for me.
Beckham?

Good call with Bach. Looks well worth their options. Great job on the submission and happily approved on time as per Feb estimate in previous RNS.
What an incredible summer to look forward to. A positive result will change the world and should deserve a Gong and a that Nobel Prize. Global front page news for sure.

The TU might give us a bit more in what GADs bring to the party, which could be very expansive.

Useful summary RockBuster . The important thing to consider about the Avacta cancer therapeutics is that even a fraction of revenue generated from chemo market would result in staggering multiples and an SP into the stratosphere. I get the feeling that even early stage indication that the AV6000 works in clinical trials would set the ball rolling.

Well done everyone. Congrats to us all. The next step in what’s going to be an amazing story

Chester is a smart outfit, they'd do it well and show the way to many others.